- Previous Close
0.4960 - Open
0.5000 - Bid 0.4960 x --
- Ask 0.4980 x --
- Day's Range
0.4980 - 0.5100 - 52 Week Range
0.2350 - 1.1200 - Volume
64,591 - Avg. Volume
101,539 - Market Cap (intraday)
109.33M - Beta (5Y Monthly) 1.50
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3900 - Earnings Date Nov 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.56
SciBase Holding AB (publ), a medical technology company, develops and sells point-of-care platforms that utilizes electrical impedance spectroscopy for the evaluation of skin disorders in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and assess skin barrier and inflammation. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.
scibase.comRecent News: SCIB.ST
View More
Performance Overview: SCIB.ST
Trailing total returns as of 10/30/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SCIB.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SCIB.ST
View MoreValuation Measures
Market Cap
108.89M
Enterprise Value
81.57M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.70
Price/Book (mrq)
2.06
Enterprise Value/Revenue
3.17
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-230.41%
Return on Assets (ttm)
-42.32%
Return on Equity (ttm)
-94.51%
Revenue (ttm)
25.71M
Net Income Avi to Common (ttm)
-59.24M
Diluted EPS (ttm)
-0.3900
Balance Sheet and Cash Flow
Total Cash (mrq)
43.27M
Total Debt/Equity (mrq)
5.37%
Levered Free Cash Flow (ttm)
-41.6M
Research Analysis: SCIB.ST
View MoreCompany Insights: SCIB.ST
SCIB.ST does not have Company Insights